患者接受跨神经病情的电神经病学
Courtney R Seigel1, Holly Martin2,3, Grace Bastin2
1Indiana University School of Medicine, Indianapolis, IN, USA. crseigel@iu.edu.
Journal of neurology
|February 23, 2024
概括
门诊电神经科对于患有各种神经疾病的患者来说是非常可接受的. 较高的医学并发症与更高的患者接受度有关,这表明它对复杂病例的有用性.
科学领域:
- 神经学 神经学
- 医疗保健服务研究 医疗服务研究
- 远程医疗远程医疗
背景情况:
- 患者接受门诊电神经神经病的确立在特定条件下.
- 有限的数据存在于跨不同神经系统疾病的teleneurology可接受性.
- 这项研究旨在比较不同神经病诊断的患者中电神经病的可接受性.
研究的目的:
- 为了比较不同神经疾病的门诊电神经病的患者接受度.
- 确定影响患者接受电神经病学的因素.
- 评估医疗复杂患者的电神经病学的可行性.
主要方法:
- 使用退伍军人事务部国家电脑神经病学计划对退伍军人的前性研究.
- 通过电话采访评估患者的可接受性,使用7分利克特等级 (3-21分).
- 使用受审查的托比特模型进行统计分析,控制人口统计,访问类型,并发病率和ICD10诊断类别.
主要成果:
- 在有可分析数据的277名患者中,平均可接受度为18.3 (SD 3.2).
- 在神经系统疾病组 (头痛,运动障碍,一般症状,其他) 中没有发现可接受性得分的显著差异.
- 更高的医学并发症是唯一独立与更高的可接受性得分相关的因素.
结论:
- 门诊电神经科对患者来说是非常可接受的,无论他们的特定神经病症状况如何.
- 患有较大的医学并发症的患者报告说,电神经病学服务的接受度增加.
- 电脑神经病理学证明了作为广泛的门诊神经病理护理的可接受和有效方式的潜力,包括医疗复杂的个体.
更多相关视频
08:22Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability
Published on: October 7, 2017
8.1K
08:54Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
Published on: June 6, 2025
245
相关概念视频
01:19Ligand-gated Ion Channels
Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that include the...
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that include the...
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...